Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal dominant nonsyndromic deafness in which the cause of the disease is a mutation in the GRHL2 gene.
Features include: Inner ear hearing loss (sensorineural hearing impairment).
Organ System | Phenotype Count | Example Features |
|---|---|---|
Ears | 1 | Inner ear hearing loss (sensorineural hearing impairment) |
GRHL2 encodes grainyhead like transcription factor 2 (625 aa). Transcription factor playing an important role in primary neurulation and in epithelial development. Highest expression in Skin Not Sun Exposed Suprapubic (41.4 TPM) and Skin Sun Exposed Lower leg (39.8 TPM).
Autosomal dominant nonsyndromic hearing loss 28 is associated with mutations in the GRHL2 gene on chromosome 8.
The GRHL2 protein participates in Positive Regulation of CDH1 Gene Transcription pathway.
GRHL2 is classified as a druggable target (Enzyme and Transcription Factor categories) with score 0.0.
Genetic testing for GRHL2 is available. Testing is considered confirmatory for diagnosis.
No clinical trials have been registered for autosomal dominant nonsyndromic hearing loss 28.
8 publications have been identified in PubMed for autosomal dominant nonsyndromic hearing loss 28. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (25%), and Basic Science / Preclinical (25%).
Bazazzadegan N (2025). [PMID: 40001331](https://pubmed.ncbi.nlm.nih.gov/40001331/). *Arch Iran Med*. [Case Report / Case Series]
Guan J (2025). [PMID: 40068948](https://pubmed.ncbi.nlm.nih.gov/40068948/). *Yi Chuan*. [Basic Science / Preclinical]
Wu J (2025). [PMID: 41225453](https://pubmed.ncbi.nlm.nih.gov/41225453/). *BMC Pediatr*. [Review / Meta-Analysis]
Xue J (2024). [PMID: 39358765](https://pubmed.ncbi.nlm.nih.gov/39358765/). *BMC Med Genomics*. [Case Report / Case Series]
Reichenberger EJ (2024). [PMID: 39165910](https://pubmed.ncbi.nlm.nih.gov/39165910/). *JBMR Plus*. [Basic Science / Preclinical]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:58 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Rive Le Gouard N (2024). [PMID: 38940299](https://pubmed.ncbi.nlm.nih.gov/38940299/). *Clin Genet*. [Review / Meta-Analysis]
Ren L (2024). [PMID: 38980994](https://pubmed.ncbi.nlm.nih.gov/38980994/). *Mol Genet Genomic Med*. [Case Report / Case Series]